Literature DB >> 30040158

EBV up-regulates PD-L1 on the surface of primary monocytes by increasing ROS and activating TLR signaling and STAT3.

Maria Saveria Gilardini Montani1, Roberta Santarelli1, Luca Falcinelli1, Roberta Gonnella1, Marisa Granato1, Livia Di Renzo1, Laura Cuomo2, Marina Vitillo2, Alberto Faggioni1, Mara Cirone1.   

Abstract

Programmed death ligand 1 (PD-L1) (also called B7-H1) is a membrane immune-modulatory protein whose overexpression on the surface of tumor cells as well as APCs impairs T-cell-mediated killing. Viruses that establish chronic infections have developed a number of strategies to escape from immune recognition including the up-regulation of PD-L1. This study shows for the first time that the human oncovirus EBV infects human primary monocytes using HLA-DR and induced a strong up-regulation of PD-L1 expression on their surface. Searching for the underlying mechanism/s leading to this immune suppressive effect, we found that EBV activated TLR signaling, increased intracellular ROS, and phosphorylated STAT3. Targeting these molecules partially reverted PD-L1 up-regulation that correlated with an altered cytokine production and a reduction of monocyte cell survival, strongly impairing the antiviral immune response. ©2018 Society for Leukocyte Biology.

Entities:  

Keywords:  EBV; MAPK; PD-L1; STAT3; TLR; monocytes

Mesh:

Substances:

Year:  2018        PMID: 30040158     DOI: 10.1002/JLB.2A0118-029RR

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  12 in total

Review 1.  Autophagy Balances Neuroinflammation in Alzheimer's Disease.

Authors:  Xuehua Cheng; Yong Wei; Zijun Qian; Li Han
Journal:  Cell Mol Neurobiol       Date:  2022-08-12       Impact factor: 4.231

Review 2.  Immunosuppressive Tumor Microenvironment and Immunotherapy of Epstein-Barr Virus-Associated Malignancies.

Authors:  Xueyi Zheng; Yuhua Huang; Kai Li; Rongzhen Luo; Muyan Cai; Jingping Yun
Journal:  Viruses       Date:  2022-05-10       Impact factor: 5.818

3.  The Roseoloviruses Downregulate the Protein Tyrosine Phosphatase PTPRC (CD45).

Authors:  Melissa L Whyte; Kelsey A Smith; Amanda Buchberger; Linda Berg Luecke; Lidya Handayani Tjan; Yasuko Mori; Rebekah L Gundry; Amy W Hudson
Journal:  J Virol       Date:  2021-06-24       Impact factor: 5.103

4.  Tobacco extracts promote PD-L1 expression and enhance malignant biological differences via mTOR in gefitinib-resistant cell lines.

Authors:  Fengqi Xiao; Yanguo Liu; Zhihui Zhang; Luojia Wang; Ting Wang; Xiuwen Wang
Journal:  Thorac Cancer       Date:  2020-06-18       Impact factor: 3.500

Review 5.  Recent Findings in the Regulation of Programmed Death Ligand 1 Expression.

Authors:  Xiangfeng Shen; Lihong Zhang; Jicheng Li; Yulin Li; Yishu Wang; Zhi-Xiang Xu
Journal:  Front Immunol       Date:  2019-06-14       Impact factor: 7.561

6.  Cytotoxic Drugs Activate KSHV Lytic Cycle in Latently Infected PEL Cells by Inducing a Moderate ROS Increase Controlled by HSF1, NRF2 and p62/SQSTM1.

Authors:  Marisa Granato; Maria Saveria Gilardini Montani; Camilla Angiolillo; Gabriella D'Orazi; Alberto Faggioni; Mara Cirone
Journal:  Viruses       Date:  2018-12-24       Impact factor: 5.048

Review 7.  Autophagy manipulation as a strategy for efficient anticancer therapies: possible consequences.

Authors:  Mara Cirone; Maria Saveria Gilardini Montani; Marisa Granato; Alessia Garufi; Alberto Faggioni; Gabriella D'Orazi
Journal:  J Exp Clin Cancer Res       Date:  2019-06-14

Review 8.  Mechanisms of PD-L1 Regulation in Malignant and Virus-Infected Cells.

Authors:  Hadia Farrukh; Nader El-Sayes; Karen Mossman
Journal:  Int J Mol Sci       Date:  2021-05-05       Impact factor: 5.923

9.  Lysyl Oxidase-Like 4 Fosters an Immunosuppressive Microenvironment During Hepatocarcinogenesis.

Authors:  Hor-Yue Tan; Ning Wang; Cheng Zhang; Yau-Tuen Chan; Man-Fung Yuen; Yibin Feng
Journal:  Hepatology       Date:  2021-05-21       Impact factor: 17.425

10.  KSHV infection skews macrophage polarisation towards M2-like/TAM and activates Ire1 α-XBP1 axis up-regulating pro-tumorigenic cytokine release and PD-L1 expression.

Authors:  Maria Saveria Gilardini Montani; Luca Falcinelli; Roberta Santarelli; Marisa Granato; Maria Anele Romeo; Nives Cecere; Roberta Gonnella; Gabriella D'Orazi; Alberto Faggioni; Mara Cirone
Journal:  Br J Cancer       Date:  2020-05-18       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.